Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on: January 16,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on:January 16,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on: May 07,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on:May 07,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on: April 06,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on:April 06,2024

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Updated on: December 28,2023

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Updated on:December 28,2023

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on: June 01,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on:June 01,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on: September 10,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on:September 10,2024

Patients with brain cancer may benefit from treatment to boost white blood cells

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisRadiation-induced lymphopenia correlated with decreased survival in patients with GBM. (A) The consort flow diagram

Updated on: January 02,2024

Patients with brain cancer may benefit from treatment to boost white blood cells

by Julia Evangelou Strait,Washington University School of Medicine in St. LouisRadiation-induced lymphopenia correlated with decreased survival in patients with GBM. (A) The consort flow diagram

Updated on:January 02,2024

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Updated on: January 30,2024

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Updated on:January 30,2024

Unveiling gender differences in cancer: New insights into genomic instability

by Health Data ScienceScientists from Peking University Health Science Center investigated sex differences in genome instability across 16 cancer types, identifying male-biased and female-biased copy

Updated on: March 30,2024

Unveiling gender differences in cancer: New insights into genomic instability

by Health Data ScienceScientists from Peking University Health Science Center investigated sex differences in genome instability across 16 cancer types, identifying male-biased and female-biased copy

Updated on:March 30,2024

Deadly form of advanced prostate cancer is common, calls for distinct treatment

by University of California, San FranciscoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A new study of prostate

Updated on: April 09,2024

Deadly form of advanced prostate cancer is common, calls for distinct treatment

by University of California, San FranciscoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A new study of prostate

Updated on:April 09,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on: March 05,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on:March 05,2024